Comparison
Abeta Amyloidosis Dutch Type C2931672 vs 17q12 Recurrent Deletion Syndrome C6011081
Clinical comparison between Abeta Amyloidosis Dutch Type and 17q12 Recurrent Deletion Syndrome for differential diagnosis and treatment planning.
Abeta Amyloidosis Dutch Type C2931672
Hereditary cerebral amyloid angiopathy from APP gene mutation. Family-linked condition. Can cause brain hemorrhage and stroke.
17q12 Recurrent Deletion Syndrome C6011081
A genetic condition from deletion on chromosome 17. Can involve developmental delays, neurological features, and potential kidney involvement. Management requires regular monitoring and supportive therapies.
6 comparison axes
Onset
Abeta Amyloidosis Dutch Type C2931672
45-65
17q12 Recurrent Deletion Syndrome C6011081
0-null
Onset patterns differ
Severity
Abeta Amyloidosis Dutch Type C2931672
severe
17q12 Recurrent Deletion Syndrome C6011081
moderate
Different severity levels
Chronic
Abeta Amyloidosis Dutch Type C2931672
Chronic
17q12 Recurrent Deletion Syndrome C6011081
Chronic
Differing course
Communicable
Abeta Amyloidosis Dutch Type C2931672
No
17q12 Recurrent Deletion Syndrome C6011081
No
Different transmission
Body System
Abeta Amyloidosis Dutch Type C2931672
neurologic
17q12 Recurrent Deletion Syndrome C6011081
congenital
Same/different system
Category
Abeta Amyloidosis Dutch Type C2931672
rare-disease
17q12 Recurrent Deletion Syndrome C6011081
genetic
Different category
Bottom line
abeta-amyloidosis-dutch-type-C2931672 and 17q12-recurrent-deletion-syndrome-C6011081 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | Abeta Amyloidosis Dutch Type C2931672 | 17q12 Recurrent Deletion Syndrome C6011081 | Discriminating power |
|---|---|---|---|
| Age at recognition | Typically recognized in adulthood, often ages 45–65. | May be evident from birth or early development. | High |
| Dominant clinical concern | Recurrent cerebral hemorrhage, stroke, or neurologic decline. | Developmental delay with possible neurologic and kidney features. | High |
| Family pattern | Family-linked APP-related condition; inheritance pattern needs genetics review. | Chromosome 17q12 deletion; may be inherited or new. | Moderate |
When to favor each condition
Choose Abeta Amyloidosis Dutch Type C2931672 when
Adult with recurrent lobar brain hemorrhage
This pattern fits hereditary cerebral amyloid angiopathy better than a congenital deletion.
Moderate
Family history of similar adult strokes
A family-linked APP-related condition should be considered.
Moderate
Progressive neurologic events after midlife
Adult onset supports Dutch-type Aβ amyloidosis over congenital disease.
Moderate
Choose 17q12 Recurrent Deletion Syndrome C6011081 when
Congenital or early developmental concerns
Early onset is more consistent with 17q12 deletion syndrome.
Moderate
Combined developmental and kidney findings
Multisystem congenital features favor chromosomal evaluation.
Moderate
Known or suspected chromosomal deletion
A documented 17q12 deletion establishes this diagnosis direction.
High
How key tests differ
| Test | Abeta Amyloidosis Dutch Type C2931672 | 17q12 Recurrent Deletion Syndrome C6011081 | Interpretation |
|---|---|---|---|
| Genetic testing | APP variant associated with Dutch-type amyloid angiopathy may be found. | Recurrent deletion involving chromosome 17q12 may be detected. | Different tests target a gene variant versus a chromosomal deletion. |
| Brain imaging | May show hemorrhage or other vascular brain injury; findings are not specific alone. | No characteristic hemorrhage pattern is established by the supplied data. | Imaging supports clinical assessment but does not replace genetics. |
| Kidney evaluation | Kidney disease is not established from the supplied description. | Monitoring may be appropriate because kidney involvement is possible. | Abnormal kidney tests need clinician interpretation and are not diagnostic alone. |
Prognosis comparison
Abeta Amyloidosis Dutch Type C2931672
- Outcome
- Potentially severe because recurrent hemorrhage or stroke may occur; exact outcomes are not established here.
- Factors
- Age, hemorrhage recurrence, neurologic deficits, and comorbidities may influence course.
17q12 Recurrent Deletion Syndrome C6011081
- Outcome
- Often described as moderate, but individual outcomes vary and are not fully established.
- Factors
- Developmental needs, neurologic features, kidney involvement, and available support may matter.
Time frame: Both are chronic; one is usually adult-onset and the other congenital or early-onset.
Prognosis should be interpreted by clinicians using confirmed genetics and individual findings.
Complications comparison
| Complication | Presentation |
|---|---|
| Brain hemorrhage or stroke | A recognized possible complication. Not established as a characteristic complication. Sudden neurologic symptoms require urgent care. |
| Developmental disability | Not the typical presenting feature in the supplied data. Developmental delay may occur. Support needs vary and should be individualized. |
| Kidney complications | Not established here. Potential kidney involvement warrants monitoring. The supplied data do not define frequency or severity. |
Patient education highlights
- HighUrgent symptoms
Sudden weakness, speech change, severe headache, seizure, or reduced consciousness needs emergency evaluation.
- HighGenetic counseling
Families may benefit from counseling about inheritance, testing, and implications for relatives.
- MediumMonitoring
Follow-up is individualized; developmental, neurologic, and possible kidney monitoring may be relevant.